| Symbol |
Name |
|
ABCC4
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ADCY9
|
adenylate cyclase 9
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AIFM1
|
apoptosis-inducing factor, mitochondrion-associated, 1
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANGPTL4
|
angiopoietin-like 4
|
|
ANXA1
|
annexin A1
|
|
APC
|
adenomatous polyposis coli
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
ARHGAP1
|
Rho GTPase activating protein 1
|
|
ASAH2
|
N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2
|
|
ATF3
|
activating transcription factor 3
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
|
ATXN3
|
ataxin 3
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCR
|
breakpoint cluster region
|
|
BHLHE40
|
basic helix-loop-helix family, member e40
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
|
BMPR1B
|
bone morphogenetic protein receptor, type IB
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRI3
|
brain protein I3
|
|
BRMS1
|
breast cancer metastasis suppressor 1
|
|
BSG
|
basigin (Ok blood group)
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
BTN3A1
|
butyrophilin, subfamily 3, member A1
|
|
C3
|
complement component 3
|
|
CA2
|
carbonic anhydrase II
|
|
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit
|
|
CACNG2
|
calcium channel, voltage-dependent, gamma subunit 2
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALR
|
calreticulin
|
|
CAPN3
|
calpain 3, (p94)
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL3L1
|
chemokine (C-C motif) ligand 3-like 1
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCND1
|
cyclin D1
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD14
|
CD14 molecule
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
CD1A
|
CD1a molecule
|
|
CD1B
|
CD1b molecule
|
|
CD1C
|
CD1c molecule
|
|
CD200
|
CD200 molecule
|
|
CD200R1
|
CD200 receptor 1
|
|
CD209
|
CD209 molecule
|
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4
|
|
CD274
|
CD274 molecule
|
|
CD28
|
CD28 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD48
|
CD48 molecule
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD99
|
CD99 molecule
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDX1
|
caudal type homeobox 1
|
|
CDX2
|
caudal type homeobox 2
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CETN2
|
centrin, EF-hand protein, 2
|
|
CFI
|
complement factor I
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHFR
|
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CISD1
|
CDGSH iron sulfur domain 1
|
|
CLCNKA
|
chloride channel, voltage-sensitive Ka
|
|
CLCNKB
|
chloride channel, voltage-sensitive Kb
|
|
CLIC1
|
chloride intracellular channel 1
|
|
CLU
|
clusterin
|
|
CNOT8
|
CCR4-NOT transcription complex, subunit 8
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
COL6A2
|
collagen, type VI, alpha 2
|
|
CREG1
|
cellular repressor of E1A-stimulated genes 1
|
|
CRLF2
|
cytokine receptor-like factor 2
|
|
CSNK2B
|
casein kinase 2, beta polypeptide
|
|
CTBP1
|
C-terminal binding protein 1
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTF1
|
cardiotrophin 1
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSL
|
cathepsin L
|
|
CUL7
|
cullin 7
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL6
|
chemokine (C-X-C motif) ligand 6
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
DCLRE1C
|
DNA cross-link repair 1C
|
|
DCPS
|
decapping enzyme, scavenger
|
|
DEFB103B
|
defensin, beta 103B
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DLL4
|
delta-like 4 (Drosophila)
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DMPK
|
dystrophia myotonica-protein kinase
|
|
DNM1L
|
dynamin 1-like
|
|
DRAP1
|
DR1-associated protein 1 (negative cofactor 2 alpha)
|
|
DUSP16
|
dual specificity phosphatase 16
|
|
E2F1
|
E2F transcription factor 1
|
|
EAF2
|
ELL associated factor 2
|
|
EDN1
|
endothelin 1
|
|
EEF1A1
|
eukaryotic translation elongation factor 1 alpha 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ENG
|
endoglin
|
|
EP300
|
E1A binding protein p300
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPHB2
|
EPH receptor B2
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ESPL1
|
extra spindle pole bodies homolog 1 (S. cerevisiae)
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
ETV6
|
ets variant 6
|
|
F10
|
coagulation factor X
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FAM20C
|
family with sequence similarity 20, member C
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBXO5
|
F-box protein 5
|
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
|
FCMR
|
Fc fragment of IgM receptor
|
|
FGF10
|
fibroblast growth factor 10
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGL2
|
fibrinogen-like 2
|
|
FHIT
|
fragile histidine triad
|
|
FIS1
|
fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae)
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FOLR1
|
folate receptor 1 (adult)
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXM1
|
forkhead box M1
|
|
FOXO4
|
forkhead box O4
|
|
FSCN1
|
fascin actin-bundling protein 1
|
|
FUT5
|
fucosyltransferase 5 (alpha (1,3) fucosyltransferase)
|
|
GC
|
group-specific component (vitamin D binding protein)
|
|
GLI1
|
GLI family zinc finger 1
|
|
GNA13
|
guanine nucleotide binding protein (G protein), alpha 13
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GRIK2
|
glutamate receptor, ionotropic, kainate 2
|
|
GRP
|
gastrin-releasing peptide
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSN
|
gelsolin
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GZMA
|
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
GZMH
|
granzyme H (cathepsin G-like 2, protein h-CCPX)
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HELB
|
helicase (DNA) B
|
|
HERC5
|
HECT and RLD domain containing E3 ubiquitin protein ligase 5
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIST1H3I
|
histone cluster 1, H3i
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGB1
|
high mobility group box 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPA8
|
heat shock 70kDa protein 8
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
HTT
|
huntingtin
|
|
HYOU1
|
hypoxia up-regulated 1
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP4
|
insulin-like growth factor binding protein 4
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IKZF3
|
IKAROS family zinc finger 3 (Aiolos)
|
|
IL10
|
interleukin 10
|
|
IL10RB
|
interleukin 10 receptor, beta
|
|
IL11
|
interleukin 11
|
|
IL17A
|
interleukin 17A
|
|
IL1B
|
interleukin 1, beta
|
|
IL20RA
|
interleukin 20 receptor, alpha
|
|
IL24
|
interleukin 24
|
|
IL25
|
interleukin 25
|
|
IL26
|
interleukin 26
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL4
|
interleukin 4
|
|
IL4I1
|
interleukin 4 induced 1
|
|
IL6
|
interleukin 6
|
|
IL7R
|
interleukin 7 receptor
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF3
|
interferon regulatory factor 3
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB5
|
integrin, beta 5
|
|
ITLN1
|
intelectin 1 (galactofuranose binding)
|
|
ITM2B
|
integral membrane protein 2B
|
|
JAK2
|
Janus kinase 2
|
|
KCNA3
|
potassium channel, voltage gated shaker related subfamily A, member 3
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNK2
|
potassium channel, two pore domain subfamily K, member 2
|
|
KCNN4
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4
|
|
KCTD15
|
potassium channel tetramerization domain containing 15
|
|
KDR
|
kinase insert domain receptor
|
|
KIAA0101
|
KIAA0101
|
|
KIFC3
|
kinesin family member C3
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
|
KLF8
|
Kruppel-like factor 8
|
|
KLHDC1
|
kelch domain containing 1
|
|
KLHL24
|
kelch-like family member 24
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LCN2
|
lipocalin 2
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
|
LIF
|
leukemia inhibitory factor
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
|
|
LIN28A
|
lin-28 homolog A (C. elegans)
|
|
LMNA
|
lamin A/C
|
|
LOC728931
|
|
|
LOX
|
lysyl oxidase
|
|
LPL
|
lipoprotein lipase
|
|
LTB
|
lymphotoxin beta (TNF superfamily, member 3)
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K6
|
mitogen-activated protein kinase kinase 6
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAPT
|
microtubule-associated protein tau
|
|
MARCH5
|
membrane-associated ring finger (C3HC4) 5
|
|
MAVS
|
mitochondrial antiviral signaling protein
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCOLN1
|
mucolipin 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MED21
|
mediator complex subunit 21
|
|
MERTK
|
MER proto-oncogene, tyrosine kinase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFN1
|
mitofusin 1
|
|
MGAT5
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase
|
|
MIR146A
|
microRNA 146a
|
|
MIR150
|
microRNA 150
|
|
MIR18A
|
microRNA 18a
|
|
MIR200C
|
microRNA 200c
|
|
MIR204
|
microRNA 204
|
|
MIR218-1
|
microRNA 218-1
|
|
MIR218-2
|
microRNA 218-2
|
|
MIR27A
|
microRNA 27a
|
|
MIR301A
|
microRNA 301a
|
|
MIR301B
|
microRNA 301b
|
|
MIR491
|
microRNA 491
|
|
MIR99A
|
microRNA 99a
|
|
MIXL1
|
Mix paired-like homeobox
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MLANA
|
melan-A
|
|
MLH1
|
mutL homolog 1
|
|
MLXIP
|
MLX interacting protein
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MN1
|
meningioma (disrupted in balanced translocation) 1
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MTDH
|
metadherin
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYOG
|
myogenin (myogenic factor 4)
|
|
NANOG
|
Nanog homeobox
|
|
NCF1
|
neutrophil cytosolic factor 1
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NDEL1
|
nudE neurodevelopment protein 1-like 1
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NMT1
|
N-myristoyltransferase 1
|
|
NMT2
|
N-myristoyltransferase 2
|
|
NODAL
|
nodal growth differentiation factor
|
|
NOG
|
noggin
|
|
NOLC1
|
nucleolar and coiled-body phosphoprotein 1
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NPC1L1
|
NPC1-like 1
|
|
NPPC
|
natriuretic peptide C
|
|
NPR3
|
natriuretic peptide receptor 3
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR2C2AP
|
nuclear receptor 2C2-associated protein
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
OCLN
|
occludin
|
|
ODC1
|
ornithine decarboxylase 1
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OLFM4
|
olfactomedin 4
|
|
OSTN
|
osteocrin
|
|
PAEP
|
progestagen-associated endometrial protein
|
|
PAFAH1B1
|
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa)
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PANX1
|
pannexin 1
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PCNT
|
pericentrin
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PIBF1
|
progesterone immunomodulatory binding factor 1
|
|
PICK1
|
protein interacting with PRKCA 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PIM2
|
Pim-2 proto-oncogene, serine/threonine kinase
|
|
PIM3
|
Pim-3 proto-oncogene, serine/threonine kinase
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLXND1
|
plexin D1
|
|
PML
|
promyelocytic leukemia
|
|
POLM
|
polymerase (DNA directed), mu
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PPP1R10
|
protein phosphatase 1, regulatory subunit 10
|
|
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like
|
|
PPP1R15A
|
protein phosphatase 1, regulatory subunit 15A
|
|
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCQ
|
protein kinase C, theta
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PRKG2
|
protein kinase, cGMP-dependent, type II
|
|
PRL
|
prolactin
|
|
PROCR
|
protein C receptor, endothelial
|
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9
|
|
PSME3
|
proteasome (prosome, macropain) activator subunit 3 (PA28 gamma; Ki)
|
|
PTBP1
|
polypyrimidine tract binding protein 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PVR
|
poliovirus receptor
|
|
PVRL1
|
poliovirus receptor-related 1 (herpesvirus entry mediator C)
|
|
RAB27B
|
RAB27B, member RAS oncogene family
|
|
RAB5A
|
RAB5A, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD51
|
RAD51 recombinase
|
|
RANBP2
|
RAN binding protein 2
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RBM7
|
RNA binding motif protein 7
|
|
RCOR1
|
REST corepressor 1
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
REST
|
RE1-silencing transcription factor
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RGS3
|
regulator of G-protein signaling 3
|
|
RGS5
|
regulator of G-protein signaling 5
|
|
RHEB
|
Ras homolog enriched in brain
|
|
RHOA
|
ras homolog family member A
|
|
RNASE7
|
ribonuclease, RNase A family, 7
|
|
RNH1
|
ribonuclease/angiogenin inhibitor 1
|
|
RORA
|
RAR-related orphan receptor A
|
|
RPS3
|
ribosomal protein S3
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RUNX3
|
runt-related transcription factor 3
|
|
S100B
|
S100 calcium binding protein B
|
|
SAT1
|
spermidine/spermine N1-acetyltransferase 1
|
|
SELL
|
selectin L
|
|
SELPLG
|
selectin P ligand
|
|
SEMA3B
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B
|
|
SEMA3E
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SETD8
|
SET domain containing (lysine methyltransferase) 8
|
|
SFTPA1
|
surfactant protein A1
|
|
SKA2
|
spindle and kinetochore associated complex subunit 2
|
|
SKI
|
SKI proto-oncogene
|
|
SLAMF6
|
SLAM family member 6
|
|
SLAMF7
|
SLAM family member 7
|
|
SLC7A6
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 6
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
|
SMAD7
|
SMAD family member 7
|
|
SMARCC1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1
|
|
SMARCD3
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3
|
|
SMARCE1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1
|
|
SMG1
|
SMG1 phosphatidylinositol 3-kinase-related kinase
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SP1
|
Sp1 transcription factor
|
|
SPON2
|
spondin 2, extracellular matrix protein
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRCIN1
|
SRC kinase signaling inhibitor 1
|
|
SSBP1
|
single-stranded DNA binding protein 1, mitochondrial
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
TAB2
|
TGF-beta activated kinase 1/MAP3K7 binding protein 2
|
|
TAB3
|
TGF-beta activated kinase 1/MAP3K7 binding protein 3
|
|
TAC1
|
tachykinin, precursor 1
|
|
TACC3
|
transforming, acidic coiled-coil containing protein 3
|
|
TACR1
|
tachykinin receptor 1
|
|
TAOK2
|
TAO kinase 2
|
|
TBC1D25
|
TBC1 domain family, member 25
|
|
TBK1
|
TANK-binding kinase 1
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TDGF1
|
teratocarcinoma-derived growth factor 1
|
|
TEAD4
|
TEA domain family member 4
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGM2
|
transglutaminase 2
|
|
THBS1
|
thrombospondin 1
|
|
THY1
|
Thy-1 cell surface antigen
|
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1
|
|
TIMD4
|
T-cell immunoglobulin and mucin domain containing 4
|
|
TIRAP
|
toll-interleukin 1 receptor (TIR) domain containing adaptor protein
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR9
|
toll-like receptor 9
|
|
TMEM14A
|
transmembrane protein 14A
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
|
TOLLIP
|
toll interacting protein
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPM2
|
tropomyosin 2 (beta)
|
|
TPP1
|
tripeptidyl peptidase I
|
|
TPPP
|
tubulin polymerization promoting protein
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TRAP1
|
TNF receptor-associated protein 1
|
|
TRIM5
|
tripartite motif containing 5
|
|
TRIP12
|
thyroid hormone receptor interactor 12
|
|
TSPO
|
translocator protein (18kDa)
|
|
TUBA1B
|
tubulin, alpha 1b
|
|
UCA1
|
urothelial cancer associated 1 (non-protein coding)
|
|
USF2
|
upstream transcription factor 2, c-fos interacting
|
|
USP7
|
ubiquitin specific peptidase 7 (herpes virus-associated)
|
|
USP9X
|
ubiquitin specific peptidase 9, X-linked
|
|
VAMP7
|
vesicle-associated membrane protein 7
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VDAC1
|
voltage-dependent anion channel 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VTN
|
vitronectin
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WNT11
|
wingless-type MMTV integration site family, member 11
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WWTR1
|
WW domain containing transcription regulator 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XRCC6P2
|
X-ray repair complementing defective repair in Chinese hamster cells 6 pseudogene 2
|
|
YBX1
|
Y box binding protein 1
|
|
YY1
|
YY1 transcription factor
|
|
ZBP1
|
Z-DNA binding protein 1
|
|
ZBTB17
|
zinc finger and BTB domain containing 17
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
